Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis

S Kaptoge, SRK Seshasai, P Gao… - European heart …, 2014 - academic.oup.com
Aims Because low-grade inflammation may play a role in the pathogenesis of coronary heart
disease (CHD), and pro-inflammatory cytokines govern inflammatory cascades, this study …

[HTML][HTML] Novel biomarkers for cardiovascular risk prediction

J Wang, GJ Tan, LN Han, YY Bai, M He… - Journal of geriatric …, 2017 - ncbi.nlm.nih.gov
Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. The
primary prevention of CVD is dependent upon the ability to identify high-risk individuals long …

Diagnostic markers of acute myocardial infarction

S Mythili, N Malathi - Biomedical reports, 2015 - spandidos-publications.com
Acute myocardial infarction (AMI) is a major cause of morbidity and mortality worldwide. The
highest risk of fatality occurs within the initial hours of onset of AMI. Thus, early diagnosis of …

Cytokines in atherosclerosis: pathogenic and regulatory pathways

A Tedgui, Z Mallat - Physiological reviews, 2006 - journals.physiology.org
Atherosclerosis is a chronic disease of the arterial wall where both innate and adaptive
immunoinflammatory mechanisms are involved. Inflammation is central at all stages of …

Circulating endothelial progenitor cells and cardiovascular outcomes

N Werner, S Kosiol, T Schiegl, P Ahlers… - … England Journal of …, 2005 - Mass Medical Soc
Background Endothelial progenitor cells derived from bone marrow are believed to support
the integrity of the vascular endothelium. The number and function of endothelial progenitor …

Pharmacological actions of statins: a critical appraisal in the management of cancer

P Gazzerro, MC Proto, G Gangemi, AM Malfitano… - Pharmacological …, 2012 - ASPET
Statins, among the most commonly prescribed drugs worldwide, are cholesterol-lowering
agents used to manage and prevent cardiovascular and coronary heart diseases. Recently …

Biomarkers of cardiovascular disease: molecular basis and practical considerations

RS Vasan - Circulation, 2006 - Am Heart Assoc
echocardiogram) may be expected to facilitate the identification of patients with chest pain of
an ischemic etiology (angina). In a patient presenting to the emergency department with …

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST …

JP Bassand, CW Hamm, D Ardissino… - European heart …, 2007 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction

RRS Packard, P Libby - Clinical chemistry, 2008 - academic.oup.com
Recent investigations of atherosclerosis have focused on inflammation, providing new
insight into mechanisms of disease. Inflammatory cytokines involved in vascular …

Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes

S Baldus, C Heeschen, T Meinertz, AM Zeiher… - Circulation, 2003 - Am Heart Assoc
Background—Polymorphonuclear neutrophils (PMNs) have gained attention as critical
mediators of acute coronary syndromes (ACS). Myeloperoxidase (MPO), a hemoprotein …